Literature DB >> 28863237

A prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polyps.

Ava R Weibman1, Julia He Huang1, Whitney W Stevens2, Lydia A Suh2, Caroline P E Price1, Alcina K Lidder1,3, David B Conley1, Kevin C Welch1, Stephanie Shintani-Smith1, Anju T Peters2, Leslie C Grammer2, Atsushi Kato2, Robert C Kern1, Robert P Schleimer1,2, Bruce K Tan1.   

Abstract

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) has a high propensity for recurrence. Studies suggest that eosinophilia influences disease severity and surgical outcomes, but the selection of sinonasal site for measuring eosinophilia has not been examined. The aim of this study was to investigate how region-specific tissue eosinophilia affects radiographic severity, comorbidity prevalence, and polyp recurrence risk following sinus surgery.
METHODS: Eosinophil cationic protein (ECP) levels in uncinate tissue (UT) and nasal polyp (NP) homogenates from 116 CRSwNP patients were measured using enzyme-linked immunosorbent assay (ELISA). Clinical history, radiographic severity, and time to polyp recurrence were obtained from electronic health records. The correlations between baseline Lund-Mackay scores and comorbidities were compared between UT and NP ECP levels. Cox regression and Kaplan-Meier analysis were then performed to assess whether UT or NP ECP better predicted recurrence. Censoring occurred at 4 years or at last follow-up if there was no endoscopic diagnosis of recurrent polyps.
RESULTS: Lund-Mackay scores were significantly correlated with UT and NP ECP (r = 0.46 and 0.26 respectively, p < 0.05). UT but not NP ECP was significantly higher in patients with asthma (p < 0.01) and aspirin-exacerbated respiratory disease (AERD) (p < 0.05). Polyp recurrence risk was only significantly higher for patients with eosinophilic UT tissue (hazard ratio [HR] = 2.84, p = 0.025). When measured in NP, eosinophilia did not predict recurrence.
CONCLUSION: Although ECP in NP was higher than in UT tissue, eosinophilia in UT tissue was a more clinically coherent biomarker of baseline radiographic severity, comorbid asthma and AERD, and prospective polyp recurrence risk than NP eosinophilia.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  Chronic sinusitis; biomarkers; disease severity; outcomes

Mesh:

Substances:

Year:  2017        PMID: 28863237      PMCID: PMC5966315          DOI: 10.1002/alr.22005

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  34 in total

Review 1.  The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis.

Authors:  Charles H Feng; Michaela D Miller; Ronald A Simon
Journal:  Am J Rhinol Allergy       Date:  2012 May-Jun       Impact factor: 2.467

2.  Relationship between postoperative recurrence rate and eosinophil density of nasal polyps.

Authors:  Fuat Tosun; Hasan Huseyin Arslan; Yildirim Karslioglu; M Salih Deveci; Abdullah Durmaz
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-07       Impact factor: 1.547

3.  Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois.

Authors:  Bruce K Tan; Aiko I Klingler; Julie A Poposki; Whitney W Stevens; Anju T Peters; Lydia A Suh; James Norton; Roderick G Carter; Kathryn E Hulse; Kathleen E Harris; Leslie C Grammer; Robert P Schleimer; Kevin C Welch; Stephanie S Smith; David B Conley; Robert C Kern; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2016-09-14       Impact factor: 10.793

4.  Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.

Authors:  Steve B Min; Cade M Nylund; Thomas P Baker; Mazer Ally; Brian Reinhardt; Yen-Ju Chen; Luz Nazareno; Fouad J Moawad
Journal:  J Clin Gastroenterol       Date:  2017-02       Impact factor: 3.062

5.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

Authors:  Wytske J Fokkens; Valerie J Lund; Joachim Mullol; Claus Bachert; Isam Alobid; Fuad Baroody; Noam Cohen; Anders Cervin; Richard Douglas; Philippe Gevaert; Christos Georgalas; Herman Goossens; Richard Harvey; Peter Hellings; Claire Hopkins; Nick Jones; Guy Joos; Livije Kalogjera; Bob Kern; Marek Kowalski; David Price; Herbert Riechelmann; Rodney Schlosser; Brent Senior; Mike Thomas; Elina Toskala; Richard Voegels; De Yun Wang; Peter John Wormald
Journal:  Rhinology       Date:  2012-03       Impact factor: 3.681

6.  A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sources.

Authors:  Sergei I Ochkur; John Dongil Kim; Cheryl A Protheroe; Dana Colbert; Rachel M Condjella; Sophie Bersoux; Richard A Helmers; Redwan Moqbel; Paige Lacy; Elizabeth A Kelly; Nizar N Jarjour; Robert Kern; Anju Peters; Robert P Schleimer; Glenn T Furuta; Parameswaran Nair; James J Lee; Nancy A Lee
Journal:  J Immunol Methods       Date:  2012-06-28       Impact factor: 2.303

7.  Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.

Authors:  Jin-Young Min; Christopher J Ocampo; Whitney W Stevens; Caroline P E Price; Christopher F Thompson; Tetsuya Homma; Julia H Huang; James E Norton; Lydia A Suh; Kathryn L Pothoven; David B Conley; Kevin C Welch; Stephanie Shintani-Smith; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Nikolai N Modyanov; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-10-04       Impact factor: 10.793

8.  Impact of mucosal eosinophilia and nasal polyposis on quality-of-life outcomes after sinus surgery.

Authors:  Zachary M Soler; David Sauer; Jess Mace; Timothy L Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2009-11-22       Impact factor: 3.497

9.  Chronic rhinosinusitis with and without nasal polyps: what is the difference?

Authors:  Wouter Huvenne; Nicholas van Bruaene; Nan Zhang; Thibaut van Zele; Joke Patou; Philippe Gevaert; Sofie Claeys; Paul Van Cauwenberge; Claus Bachert
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

10.  Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania.

Authors:  Xiangdong Wang; Nan Zhang; Mingyu Bo; Gabriele Holtappels; Ming Zheng; Hongfei Lou; Hong Wang; Luo Zhang; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2016-07-15       Impact factor: 10.793

View more
  6 in total

1.  Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention.

Authors:  Justin H Turner; Ping Li; Rakesh K Chandra
Journal:  Int Forum Allergy Rhinol       Date:  2018-06-08       Impact factor: 3.858

Review 2.  Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis.

Authors:  Anna G Staudacher; Anju T Peters; Atsushi Kato; Whitney W Stevens
Journal:  Ann Allergy Asthma Immunol       Date:  2020-01-30       Impact factor: 6.347

3.  Longitudinal stability of chronic rhinosinusitis endotypes.

Authors:  Kristen L Yancey; Ping Li; Li-Ching Huang; Quanhu Sheng; Rakesh K Chandra; Naweed I Chowdhury; Justin H Turner
Journal:  Clin Exp Allergy       Date:  2019-10-03       Impact factor: 5.018

4.  Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines.

Authors:  Justin H Turner; Rakesh K Chandra; Ping Li; Kemberlee Bonnet; David G Schlundt
Journal:  J Allergy Clin Immunol       Date:  2018-02-13       Impact factor: 10.793

5.  Radiographic disease severity in chronic rhinosinusitis patients and health care utilization.

Authors:  Mitesh P Mehta; Kevin Hur; Caroline P E Price; Stephanie Shintani-Smith; Kevin C Welch; David B Conley; Robert C Kern; Bruce K Tan
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-18

Review 6.  Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop.

Authors:  Robert Naclerio; Fuad Baroody; Claus Bachert; Benjamin Bleier; Larry Borish; Erica Brittain; Geoffrey Chupp; Anat Fisher; Wytske Fokkens; Philippe Gevaert; David Kennedy; Jean Kim; Tanya M Laidlaw; Jake J Lee; Jay F Piccirillo; Jayant M Pinto; Lauren T Roland; Robert P Schleimer; Rodney J Schlosser; Julie M Schwaninger; Timothy L Smith; Bruce K Tan; Ming Tan; Elina Toskala; Sally Wenzel; Alkis Togias
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.